Potential side effects of GLP-1 medications like semaglutide and tirzepatide may include nausea, vomiting, diarrhea, or constipation
231,284 Summary of the evidence Evidence for the use of incretin-based therapies in a CVD primary prevention cohort largely draws from trials involving people with type 2 diabetes
Berk M, Copolov D, Dean O, Lu K, Jeavons S, Schapkaitz I, Anderson-Hunt M, Judd F, Katz F, Katz P, Ording-Jespersen S, Little J, Conus P, Cuenod M, Do KQ, Busha AI: N-acetyl cysteine as a glutathione precursor for schizophreniaa double-blind, randomized, placebo-controlled trial
IV options may involve a brief needle placement, similar to other IV therapy visits
Food and Drug Administration responded Feb